From StructContinue beyond “Veeva’s Supplier Is Also Building a Rival”Back to the brief ↗Feed / LLY

Eli Lilly and Company

LLY

Healthcare · 1,191.84 +1.9% today

You’ve read what changed. Here’s whether the market is confirming it.

IsolatedMarket checked 6 Aug, 15:55 GMT-4

Jodie situation report

Eli Lilly and Company's current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 26 directly disclosed connections are confirming.

Company+1.9% todayVolume comparison unavailable
Market group0 of 1 activeDrug Manufacturers · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • Zepbound demand is driving U.S. growth, while lower realized prices, including cash-pay reductions, are offsetting part of the increase.

Invalidation: The isolated read changes if LLY's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind LLY

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

CAHCardinal Health, Inc.distributorFeb 12, 2026 ▾

“In 2025, 2024, and 2023, three wholesale distributors in the U.S.—McKesson Corporation, Cencora, Inc., and Cardinal Health, Inc.—each accounted for a significant percentage of our consolidated revenue.”

Depended on by

BEAMBeam Therapeutics Inc.partnerMay 7, 2026 ▾

“Verve Therapeutics and Eli Lilly and Company We are party to a license agreement, or the Verve Agreement, with Verve Therapeutics, Inc., or Verve, pursuant to which we granted Verve exclusive worldwide licenses under our base editing technologies for human th…”

Filing peers

ANIPJNJTEVA

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 29 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

LLY is currently a Leader in the organic co-movement group Drug Manufacturers. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for LLY; it is not active in the latest market snapshot.